Niki BioSolutions, Inc.
NIKI- Exchange
- Nasdaq
- Industry
- Measuring & Controlling Devices, NEC
- SEC CIK
- 0001734005
No open-market purchases or sales by Niki BioSolutions, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $74.2K in total; no superinvestor holds it.
Holders of 5% or more of NIKI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Niki BioSolutions, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Sheinerman Kira | 13D | 51.56%1.52M shares | New | Jul 24, 20261 filing | Jul 24, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Niki BioSolutions, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 24, 20264:31 PM ET | Sheinerman Kira | 13D | 51.56%1.52M shares | New | Jul 20, 2026 | SEC |
| May 15, 20257:10 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G/A | 0.00%0 shares | −7.20 ppfrom 7.20%Below 5% | Mar 31, 2025 | SEC |
| Jan 10, 20254:15 PM ET | Scoggin Management LPand 4 others | 13G | 0.00%0 shares | NewBelow 5% | Jan 2, 2025 | SEC |
| Jan 6, 20254:13 PM ET | L1 Capital Global Opportunities Master Fund, Ltd. | 13G | 7.20%383.8K shares | New | Jan 2, 2025 | SEC |
| Apr 16, 2024 | Lui Darren | 13D/AOld format | – | – | – | SEC |
| Feb 2, 2024 | Hudson Bay Capital Management LP | 13G/AOld format | – | – | – | SEC |
| May 24, 2023 | Lui Darren | 13D/AOld format | – | – | – | SEC |
| Feb 7, 2022 | Hudson Bay Capital Management LP | 13GOld format | – | – | – | SEC |
| Jun 1, 2021 | Huen Ian Chung Yuen | 13D/AOld format | – | – | – | SEC |
| Feb 8, 2021 | Hudson Bay Capital Management LP | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Niki BioSolutions, Inc. shares.
No Form 144 notices for Niki BioSolutions, Inc. are on file.